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A B S T R A C T   
At least six small alternative-frame open reading frames (ORFs) overlapping well-characterized SARS-CoV-2 
genes have been hypothesized to encode accessory proteins. Researchers have used different names for the same 
ORF or the same name for different ORFs, resulting in erroneous homological and functional inferences. We 
propose standard names for these ORFs and their shorter isoforms, developed in consultation with the Corona-
viridae Study Group of the International Committee on Taxonomy of Viruses. We recommend calling the 39 
codon Spike-overlapping ORF ORF2b; the 41, 57, and 22 codon ORF3a-overlapping ORFs ORF3c, ORF3d, and 
ORF3b; the 33 codon ORF3d isoform ORF3d-2; and the 97 and 73 codon Nucleocapsid-overlapping ORFs ORF9b 
and ORF9c. Finally, we document conflicting usage of the name ORF3b in 32 studies, and consequent erroneous 
inferences, stressing the importance of reserving identical names for homologs. We recommend that authors 
referring to these ORFs provide lengths and coordinates to minimize ambiguity caused by prior usage of alter-
native names.   
1. Introduction 
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is 
the recently identified strain (F.Wu et al., 2020a; Zhou et al., 2020; Zhu 
et al., 2020) of the species Severe acute respiratory syndrome-related 
coronavirus in the family Coronaviridae (subgenus Sarbecovirus, genus 
Betacoronavirus, subfamily Orthocoronavirinae) (Gorbalenya et al., 2020) 
that is the causative agent of coronavirus disease 2019 (COVID-19). 
Characterization of the SARS-CoV-2 proteome is vital for understanding 
its molecular biology and for development of countermeasures against 
the COVID-19 pandemic. Of particular interest are proteins that are 
unique to SARS-CoV-2, differ substantially from their SARS-CoV 
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homologs, or have not been well characterized in other viruses of this 
species. 
Coronaviruses have positive-sense single-stranded RNA genomes 
that encode proteins expressed from genomic and subgenomic RNAs 
using complex regulation at the transcriptional, translational, and post- 
translational levels (Fung et al., 2016; Fung and Liu, 2018; Sola et al., 
2015). Some of the protein-coding open reading frames (ORFs) are 
conserved across coronaviruses, with homologs in all strains, and were 
named according to a uniform coronavirus-wide nomenclature (de 
Groot et al., 2012). At the 5′ end are two large ORFs, ORF1a and ORF1b. 
ORF1a encodes polyprotein pp1a, and the combination of ORF1a and 
ORF1b encodes polyprotein pp1ab via a programmed frameshift. Poly-
proteins pp1a and pp1ab are proteolytically processed to yield 11 and 15 
non-structural proteins (“nsp’s”), respectively (16 unique, nsp1-nsp16). 
These include the 3C-like cysteine proteinase (nsp5), RNA-dependent 
RNA polymerase (nsp12), helicase (nsp13), and exonuclease (nsp14) 
(Snijder et al., 2003). The name ORF1ab is sometimes used to refer to the 
two ORFs combined via the frameshift. However, we refer to ORF1a and 
ORF1b as separate ORFs following common practice in the nidovirus 
field motivated by their large sizes and small overlap, despite the fact 
that ORF1b begins at a frameshift site rather than a start codon, unlike 
the other ORFs we discuss here. The other ORFs conserved across 
coronaviruses encode, from 5′ to 3′, S (Spike protein), E (Envelope), M 
(Membrane), and N (Nucleocapsid). Other “accessory” ORFs, located in 
the region downstream of ORF1b, may be species-specific or present 
only in some strains of a species. 
SARS-CoV-2 has a full complement of ORFs previously identified in 
other viruses of the species Severe acute respiratory syndrome-related 
coronavirus, which includes the prototype SARS-CoV, the causative 
agent of the 2002–2003 SARS outbreak. In addition to the ORFs com-
mon to all coronaviruses these include, from 5′ to 3′, the accessory genes 
ORF3a, ORF6, ORF7a, ORF7b, and ORF8 (split into ORF8a and ORF8b 
in some SARS-CoV isolates) (Cui et al., 2019; Liu et al., 2014; Wu et al., 
2020a). Because of the unprecedented interest in SARS-CoV-2, its pro-
teome has been extensively investigated by various experimental and 
computational techniques. One additional independent ORF, ORF10, 
and several additional ORFs overlapping S, ORF3a, and N in alternative 
positive-sense reading frames have been hypothesized to encode func-
tional proteins. Some of these alternative-frame ORFs are unique to 
SARS-CoV-2, some are completely or partially homologous to ones 
already described for SARS-CoV, and one is present in SARS-CoV but was 
not identified until the SARS-CoV-2 genome was investigated. 
Alternative-frame ORFs could be translated from the same subgenomic 
RNA as the main ORF via leaky scanning or internal ribosome entry, 
from a subgenomic RNA specific to the alternative-frame ORF, or via a 
translational frameshift (Di et al., 2017; Firth and Brierley, 2012; Iri-
goyen et al., 2016; Kim et al., 2020b; Liu and Inglis, 1992; O’Connor and 
Brian, 2000; Thiel and Siddell, 1994). Due in part to the biological and 
evolutionary complexity of these ORFs and the incremental nature of 
scientific discovery, different research groups have assigned different 
names to the alternative-frame ORFs, which has complicated clear sci-
entific communication. 
Here we propose a standard set of names for these overlapping SARS- 
CoV-2 ORFs for use by the scientific community in order to facilitate 
unambiguous communication and minimize confusion while the coding 
potential and biological function of these ORFs continues to be 
investigated. 
2. Results and discussion 
2.1. SARS-CoV-2 overlapping ORFs and their ambiguous names 
The term “open reading frame” or “ORF” has been used with slightly 
different meanings by different authors. Here we use the term to mean 
any contiguous stretch of RNA codons beginning with a start codon, 
ending with a stop codon, and with no intermediate in-frame stop 
codons. Given appropriate evidence, the 5′ end of the ORF might be 
moved to a site with a known stop codon readthrough or frameshift 
signal, as in the case of ORF1b, in order to accommodate the complexity 
of genome expression in viruses. (Note that, although we require an ORF 
to end with a stop codon, we do not include the stop codon when we 
report the lengths and coordinates of the ORF.) We do not require that 
an ORF exceeds some minimum length or that undisputed evidence is 
available for its translation into a protein. In what follows, we will only 
be discussing ORFs with AUG start codons, but our definition would 
include ORFs with other start codons (typically near-cognate to AUG, 
such as CUG). By this definition, the conceptual translation of the 
nucleotide sequence using a codon table determines whether a genome 
region is an ORF, whereas experimental or computational evidence is 
needed to determine if an ORF is indeed translated and encodes a 
functional protein during virus infection. This evidence may come from, 
but is not limited to, ribosome profiling, protein or peptide detection, 
and observation of evolutionary signals. Although a large number of 
ORFs satisfy our definition, we will only be discussing ORFs for which 
some evidence has suggested translation. Their consideration would 
benefit from having agreed nomenclature, even if for some of them this 
evidence may not pass the test of time. 
At least six ORFs overlapping S, ORF3a, and N in alternative reading 
frames have been hypothesized to encode functional proteins. These 
ORFs are detailed in Fig. 1 and Table 1, and issues relating to their 
naming are discussed in the following paragraphs. 
UniProt (The UniProt Consortium, 2019) annotates two ORFs over-
lapping N in a different reading frame, namely a 97 codon ORF with 
coordinates 28284-28574, which they call ORF9b, and a 73 codon ORF 
with coordinates 28734-28952, which they call ORF14. (As a result of 
our recommendation, the 73 codon ORF is called ORF9c beginning with 
UniProt release 2021_01.) The name ORF14, which is out of sequence 
from the other SARS-CoV-2 ORF names, dates back to the 2003 paper 
that introduced the SARS-CoV genome (Marra et al., 2003), which 
numbered all ORFs sequentially, including overlapping ORFs. Later 
papers renumbered so that overlapping ORFs were distinguished using 
different letters following a shared number, but the name ORF14 
continued to be used by some authors whereas others used the name 
ORF9c. Various authors have referred to the 97 and 73 codon 
SARS-CoV-2 ORFs overlapping N, respectively, as ORF9a and ORF9b 
(Cagliani et al., 2020; Davidson et al., 2020; Wu et al., 2020a), ORF9b 
and ORF9c (Gordon et al., 2020; Michel et al., 2020; Nelson et al., 
2020b), or ORF13 and ORF14 (Lu et al., 2020), resulting in ambiguity 
about whether ORF9b refers to the 97 or 73 codon ORF. 
Biological and evolutionary complexity have engendered even 
greater confusion about the names of ORFs overlapping ORF3a. SARS- 
CoV contains an alternative-frame 154 codon ORF, ORF3b, that 
partially overlaps both ORF3a and E (Chan et al., 2005), but the ho-
mologous 155 codon region in SARS-CoV-2 contains several in-frame 
stop codons. The longest alternative-frame ORF overlapping 
SARS-CoV-2 ORF3a is the 57 codon ORF with coordinates 25524-25694 
that overlaps a 5′-proximal portion of ORF3a that has no homology to 
SARS-CoV ORF3b (Fig. 1), though this ORF is truncated to 13 codons in a 
substantial fraction of isolates (Lu et al., 2020). Because there is no 
SARS-CoV-2 ORF of comparable length in the region homologous to 
SARS-CoV ORF3b, Chan et al. (2020) referred to this 57 codon ORF as 
ORF3b (the paper does not explicitly state the length or coordinates, and 
ORF3b is not included in the corresponding NCBI record, accession 
MN975262, but the ORF can be inferred from the amino acid sequence 
specified in their Fig. 4). However, Konno et al. used the name ORF3b to 
refer to the 22 codon ORF with coordinates 25814-25879 at the 5′ end of 
the region homologous to SARS-CoV ORF3b, which they reported to be 
an interferon antagonist when expressed from a plasmid (Konno et al., 
2020b), a property that had previously been reported for the much 
longer SARS-CoV ORF3b (Kopecky-Bromberg et al., 2007). Adding to 
the potential for confusion, the non-homologous 57 codon ORF over-
lapping ORF3a has also been reported to function as an interferon 
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antagonist in a paper that also referred to it as ORF3b (Lu et al., 2020). 
The 57 codon ORF was predicted to be translated and functional based 
on a statistical test (Schlub et al., 2018) for unexpectedly long over-
lapping ORFs, a ribosome profiling analysis, and a dN/dS analysis 
comparing SARS-CoV-2 to pangolin-CoV GX/P5L, and was named 
ORF3c in an early preprint (Nelson et al., 2020a), but its name was 
changed to ORF3d in the final published version (Nelson et al., 2020b) to 
reflect the consensus reported here. It was also predicted to be a bona 
fide gene using an independent sequence composition analysis method, 
but left unnamed (Pavesi, 2020). Complicating matters further, a ribo-
some profiling study reported evidence for translation of a 33 codon 
isoform of the 57 codon ORF that starts at a downstream in-frame AUG 
(coordinates 25596-25694), calling it ORF3a.iORF2, but did not obtain 
evidence that the full 57 codon isoform is translated (Finkel et al., 2020). 
As this example illustrates, some proteins have more than one potential 
start site and it can be difficult to determine which are functionally 
important. Other studies that discuss the 22 or 57 codon ORFs are listed 
in Table 2 and Supplementary Table 1. 
A third ORF overlapping ORF3a, the 41 codon ORF with coordinates 
25457-25579, was proposed to be translated based on synonymous 
constraint across 6 closely-related strains of the species and called 
ORF3h (Cagliani et al., 2020). This ORF was independently identified 
using ribosome profiling (Finkel et al., 2020), by synonymous constraint 
in a larger group of strains (Firth, 2020), and using evolutionary sig-
natures of protein-coding regions (Jungreis et al., 2021), and referred to 
as ORF3a.iORF1, ORF3c, and ORF3c in these three respective studies, 
with additional evidence of purifying selection reported by comparing 
different SARS-CoV-2 isolates (Nelson et al., 2020b). Adding to the 
confusion, this ORF has also been referred to as 3b protein (Pavesi, 
2020). Interestingly, the 41 codon and 57 codon ORFs have a 59-nucle-
otide overlap (including the stop codon of the former), so if both encode 
functional proteins then this region of ORF3a would be translated in the 
main reading frame and both alternative reading frames, three frames in 
total (ORFs 3a, 3c and 3d, Fig. 1B). Translation of three genes over-
lapping the same sites in different reading frames is rare but known to 
occur in at least one other virus, namely Env, Tat, and Rev in HIV-2 
(Bakouche et al., 2013). 
Lastly, the 39 codon ORF with coordinates 21744-21860 overlapping 
the Spike protein was found to show evidence of translation in a ribo-
some profiling experiment (Finkel et al., 2020). The sequence of this 
ORF displays evidence of purifying selection between human hosts, 
using a πN/πS method intended for use with overlapping genes (Nelson 
et al., 2020b). 
Ambiguity in the usage of the name ORF3b has been particularly 
confusing. Two of the earliest papers about the SARS-CoV-2 genome 
used the term ORF3b to mean different genomic regions: Wu et al. show 
ORF3b as the region homologous to SARS-CoV ORF3b in their Fig. 1 and 
their Supplementary Table 6 without noting the in-frame stop codons (F. 
Wu et al., 2020a), whereas Chan et al. use the name ORF3b to refer to 
the 57 codon ORF, which has no homology to SARS-CoV ORF3b (Chan 
Fig. 1. Browser image of recommended names for overlapping ORFs. UCSC Genome Browser images showing our recommended names and the number of amino 
acids (below name) for overlapping ORFs (light green or pink background for ORFs whose codons are shifted 1 or 2 nucleotides, respectively, in the 3′ direction from 
those of the main ORF, white background). AUG (green) and stop codons (red) are shown in each of three positive-sense genomic reading frames. (A.). 5′ end of Spike 
ORF (S) containing ORF2b (39 codons). B. ORF3a containing ORFs 3c (41 codons), 3d (57 codons), 3d-2 (33 codons), and 3b (22 codons). The region homologous to 
SARS-CoV ORF3b, which overlaps the 3′ half of ORF3a and the 5′ end of the envelope protein ORF (E) is also shown (light blue background). Note that ORFs 3a, 3c, 
and 3d are in different reading frames (+0, +1, and +2, respectively), so the 59 nucleotide region common to all three could be a rare example of RNA translated in 
three different reading frames. C. Nucleocapsid ORF (N) containing ORFs 9b (97 codons) and 9c (73 codons). (For interpretation of the references to colour in this 
figure legend, the reader is referred to the Web version of this article.) 
Table 1 
Recommended standard names. Recommended standard names for each of six ORFs overlapping S, ORF3a, or N, in 5′–3′ order, and the shorter isoform of ORF3d, with 
number of codons, coordinates, and a list of other names that have been used in previous publications or preprints. Codon counts and coordinates do not include the 
stop codon. Coordinates are with respect to the Wuhan-Hu-1 reference genome (NCBI: NC_045512.2). Frame +1 or +2 indicates that codons are shifted one or two 
nucleotides, respectively, in the 3′ direction from codons in the main (larger) ORF, which occupies frame +0.  
Recommended ORF name Length (codons) Coordinates Frame relative to main (+0) ORF Other names used (not recommended) SARS-CoV homolog 
ORF2b 39 21744-21860 +1 (S) S.iORF1 None 













ORF3b 22 25814-25879 +1 (ORF3a)  5′ end of ORF3b 
ORF9b 97 28284-28574 +1 (N) ORF9a, N.iORF1 ORF9b 
ORF9c 73 28734-28952 +1 (N) ORF9b, ORF14 ORF9c, ORF14  
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et al., 2020). At the time of writing, at least 30 subsequent published 
papers or preprints have used the term ORF3b to refer to one or both of 
these two ORFs, many of which provide little if any information from 
which the reader might deduce which ORF is being referred to (Table 2, 
Supplementary Table 1). For example, a recent report about the anti-
body response to SARS-CoV-2 ORF3b (Hachim et al., 2020) does not 
state which ORF3b is referred to, only that proteins were chosen based 
on previous studies, and citing the two aforementioned papers (Chan 
et al., 2020; Wu et al., 2020a), which have different definitions of 
ORF3b. We were able to infer from the PCR primers in their Supple-
mentary Table 5 (Hachim et al., 2020) (confirmed by personal 
communication) that it refers to the 57 amino acid protein. A subsequent 
preprint about the 22 amino acid protein cited the Hachim et al. study 
(Hachim et al., 2020) of the 57 amino acid protein as evidence of 
expression (Konno et al., 2020a), though this was corrected in the 
published version (Konno et al., 2020b). On the other hand, a report 
about interferon evasion (Xia et al., 2020) refers to one of the investi-
gated ORFs as ORF3b, without providing coordinates, but we were able 
to infer from the PCR primers in their Supplementary Table S1 that the 
amplified region was the 155 codon SARS-CoV-2 region homoloous to 
SARS-CoV ORF3b, so presumably in this case it was the 22 codon ORF 
that was expressed, since that is at the 5′ end of this region. Furthermore, 
at least five review papers discuss the 57 codon and 22 codon ORFs 
overlapping ORF3a as if they were the same entity (Supplementary 
Table 1). Particularly confusing is one review that mentions ORF3b 
without providing coordinates and depicts it graphically as the ORF at 
the 3′ end of the SARS-CoV-2 region homologous to SARS-CoV ORF3b 
(overlapping the 3′ end of ORF3a and the 5′ end of E), but we can infer 
from the cited reference that they are referring to the 22 codon ORF at 
the 5′ end of the homologous region (Sa Ribero et al., 2020). We know of 
at least one instance of similar confusion for ORF9b: Davidson et al. 
(2020) report that they “could not detect peptides from ORF9b as 
described by Bojkova et al., 2020”, but “peptides corresponding to the 
ORF9a protein were identified”; however, Davidson’s ORF9a and Boj-
kova’s ORF9b are different names for the same 97 amino acid protein, 
and Davidson’s ORF9b is the 73 amino acid protein, for which Bojkova 
et al. also did not find peptides (Bojkova et al., 2020), so the two studies 
detected the same N-overlapping protein after all. Examples of confusion 
caused by inconsistent naming continue to accumulate rapidly. 
2.2. Consensus nomenclature for SARS-CoV-2 overlapping ORFs and 
isoforms 
After discussions with many of the researchers that have published 
evidence related to overlapping ORFs in SARS-CoV-2, and in consulta-
tion with members of the Coronaviridae Study Group of the International 
Committee on Taxonomy of Viruses, we propose consensus 
nomenclature for the six aforementioned overlapping ORFs, and the 
shorter isoform of ORF3d (Table 1, Fig. 1). 
Our naming decisions were motivated by the following consider-
ations. First, we strongly recommend using the same name as the SARS- 
CoV homolog where one exists. This rule is in agreement with the pre-
vailing practice for ORF and protein naming by the Coronaviridae Study 
Group. This facilitates the transfer of knowledge in the coronavirus field 
and cross-communication between research on SARS-CoV-2, SARS-CoV, 
and other viruses of the species Severe acute respiratory syndrome-related 
coronavirus. The importance of this rule can be appreciated by imagining 
a scenario in which researchers use the name “hemoglobin” to refer to 
hemoglobin (homologous) in one eukaryotic species, but to insulin (not 
homologous) in another — accurate transfer of knowledge would be 
error-prone indeed. Practically, homology recognition is based on 
analysis of sequence and structure similarity which is not always 
straightforward for small ORFs unless assisted by other considerations 
like genome collinearity (synteny). However, we recommend that re-
searchers naming ORFs make every possible effort to determine whether 
there is homology to ORFs in related strains or species, and avoid names 
that could lead to mistaken assumptions of homology or lack thereof. At 
least eight studies using the name ORF3b to refer to the 57 codon SARS- 
CoV-2 ORF overlapping ORF3a (following Chan et al. (2020)) have 
mistakenly assumed homology and a possible functional relationship to 
SARS-CoV ORF3b due to this departure from the homology rule (Sup-
plementary Table 1). The application of the same-name-for-homologs 
rule to ORF9b is unambiguous, because SARS-CoV and SARS-CoV-2 
encode full-length homologs. On the other hand, there are several 
small ORFs within the region of the SARS-CoV-2 genome homologous to 
SARS-CoV ORF3b, but to our knowledge only the ORF at the 5′ end of 
this region, beginning at the AUG codon homologous to the start codon 
of SARS-CoV ORF3b, has been proposed to be protein-coding (Konno 
et al., 2020b). Thus, we assign the name ORF3b to the 22 codon ORF, in 
line with prior studies of ORFs of various lengths in bat viruses of this 
species homologous to the 5′ end of SARS-CoV ORF3b (Zhou et al., 
2012). 
Second, we maintain the convention of naming overlapping ORFs as 
ORF{Number1}{letter}, where “Number1” is the number of the main 
ORF (note that the numeric names of S and N are ORF2 and ORF9a, 
respectively (Inberg and Linial, 2004)) and “letter” is a lower case letter. 
We reserve “a” for the main ORF and default to sequential (alphabetical) 
letters to name additional overlapping ORFs in 5′–3′ order, but retain the 
flexibility to accommodate the same-name-for-homologs rule or histor-
ical usage. In the case of ORFs overlapping ORF3a, “a” is taken by the 
main ORF and “b” by the SARS-CoV homolog. Thus, we have named the 
remaining two overlapping ORFs 3c and 3d in 5′–3′ order even though 
they occur 5′ of ORF3b. In the case of ORF9c, we choose to use “c” 
because it is 3′ of ORF9b, and because the homologous ORF in SARS-CoV 
Table 2 
ORF3b studies. Thirty two studies that use the name “ORF3b”, but do not distinguish the 22 codon and 57 codon ORFs as separate entities. Information about what each 
study was investigating and how we determined the ORF referred to is provided in Supplementary Table 1.  
ORF called 
“ORF3b” in study 
Recommended 
name 
Study type Studies (first author and citation) 
22 codon ORF ORF3b Genome report (Wu et al., 2020a) 
Empirical (Konno et al., 2020b; Lokugamage et al., 2020; Xia et al., 2020; Zhang et al., 2020) 
Review Sa Ribero et al. (2020) 
57 codon ORF ORF3d Genome Report Chan et al. (2020) 
Empirical (Banerjee et al., 2020; Gordon et al., 2020; Hachim et al., 2020; Hayn et al., 2020; Lam et al., 2020;  
Laurent et al., 2020; Samavarchi-Tehrani et al., 2020.; St-Germain et al., 2020) 
Laboratory resource - sequence 
clone collection 
(Kim et al., 2020a) 
Computational (Michel et al., 2020; Pasquier and Robichon, 2020; Sadegh et al., 2020) 
Review (Celik et al., 2020; Garofalo et al., 2020; Helmy et al., 2020; Taefehshokr et al., 2020; Wu et al., 
2020b; Yang et al., 2020; Yi et al., 2020; Yoshimoto, 2020; Zinzula, 2020) 
Unclear Unclear Empirical (Lei et al., 2020; Nabeel-Shah et al., 2020; Yuen et al., 2020) 
Computational Sun (2020)  
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has sometimes been called ORF9c (though it has also been called 
ORF14). 
Finally, we extend our convention by naming smaller isoforms of 
overlapping ORFs using alternative start codons according to the tem-
plate ORF{Number1}{letter}{-}{Number2}. Specifically, we introduce 
the name ORF3d-2 for the 33 codon isoform of ORF3d. Whether either, 
both, or neither of these two isoforms encode a functional protein has 
yet to be determined, so we have chosen to name the shorter isoform in 
case it is the only functional isoform, but use a name that relates it to 
ORF3d in case both are functional. There are several other sub-ORFs that 
have been proposed to be translated (Finkel et al., 2020) but we have not 
assigned names to them because, as far as we know, ORF3d-2 is the only 
one for which anyone has proposed that the shorter form is translated 
but the longer one is not. If, in the future, names are needed for other 
smaller isoforms of overlapping ORFs using alternative start codons, we 
suggest using a naming strategy that is analogous to ORF3d-2. 
While researchers have presented experimental or computational 
evidence of translation or function for each of the six overlapping ORFs 
discussed here, a final consensus in the community has not yet been 
achieved. We would like to emphasize that in choosing names we are not 
intending to imply anything about the strength of evidence for trans-
lation or function of any of these ORFs, or parts thereof. With the 
humbling recognition that our knowledge of coronavirus biology in 
general and the SARS-CoV-2 genome in particular is far from complete, 
we have tried to suggest naming rules with sufficient flexibility to handle 
future discoveries. 
3. Conclusions 
We have proposed standard names for six SARS-CoV-2 ORFs and one 
shorter isoform that have been hypothesized to encode accessory pro-
teins. The ORF names we have recommended here have been endorsed 
by several members of the Coronaviridae Study Group of the Interna-
tional Committee on Taxonomy of Viruses, namely Stanley Perlman, 
Bart L Haagmans, and Benjamin W Neuman, and two coauthors John 
Ziebuhr and Alexander E. Gorbalenya; by the other coauthors of this 
paper, who represent many of the groups that initially proposed or re-
ported additional evidence for the protein-coding status of some of these 
ORFs; and by the virus curator of SwissProt/UniProt, Philippe Lemer-
cier. We hope that future publications will adopt the recommended 
names, including the published versions of any current preprints that 
refer to these ORFs, in order to facilitate unambiguous communication 
and minimize confusion. We also recommend that authors referring to 
any of these ORFs explicitly provide the length or genome coordinates 
with respect to the reference SARS-CoV-2 genome Wuhan-Hu-1 (NCBI: 
NC_045512.2), and report the name used in any cited paper if it is 
different. These practices should help to resolve ambiguities caused by 
names that have already appeared in the literature. 
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